Advertisement

NuVasive, Inc. NUVA

Set alert

Price alert · NUVA

All alert types
39.75 0.00 0.00%

At close · Aug 31

39.51 Day range 40.96

52-week range unavailable

Open
40.62
Prev close
39.75
Mkt cap
2.26B
Vol
30.59M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
39.51
High
40.96
Forward P/E
16.86
Beta
1.07
Short ratio
10.39
Inst. own
112.85%
Dividend
0.00
Ex-div date
Earnings
Aug 2, 2023
50-d avg
40.46
200-d avg
41.49
1y target
48.73

2Y chart

Chart tools
Interval

Events in this range
  • May 4, 2022Earnings: —; estimate 0.38; surprise —%
  • Aug 3, 2022Earnings: —; estimate 0.55; surprise —%
  • Nov 9, 2022Earnings: —; estimate 0.53; surprise —%
  • Feb 22, 2023Earnings: —; estimate 0.49; surprise —%
  • Feb 23, 2023Rating: JP Morgan · — → Neutral
  • May 10, 2023Earnings: —; estimate 0.41; surprise —%
  • May 11, 2023Rating: Morgan Stanley · Equal-Weight → Equal-Weight
  • May 11, 2023Rating: RBC Capital · Outperform → Outperform
  • May 12, 2023Rating: Barclays · Overweight → Overweight
  • May 15, 2023Rating: RBC Capital · Outperform → Outperform
  • May 31, 2023Rating: Morgan Stanley · Equal-Weight → Equal-Weight
  • Aug 2, 2023Earnings: —; estimate 0.56; surprise —%
Signals (94)
NameDateAgo
MACD: Buy SignalAug 28, 20233 years ago
SMA: BearishAug 3, 20233 years ago
SMA: BearishJul 31, 20233 years ago
MACD: Sell SignalJul 25, 20233 years ago
MACD: Buy SignalJul 11, 20233 years ago
SMA: BullishJul 10, 20233 years ago
SMA: BullishJul 10, 20233 years ago
MACD: Sell SignalJul 6, 20233 years ago
SMA: BearishJul 5, 20233 years ago
SMA: BullishJun 29, 20233 years ago
SMA: BearishJun 26, 20233 years ago
SMA: BullishJun 22, 20233 years ago
SMA: BearishJun 20, 20233 years ago
SMA: BullishJun 15, 20233 years ago
MACD: Buy SignalJun 6, 20233 years ago
RSI: OversoldMay 24, 20233 years ago
SMA: BearishMay 18, 20233 years ago
SMA: BullishMay 17, 20233 years ago
SMA: BearishMay 16, 20233 years ago
MACD: Sell SignalMay 1, 20233 years ago
SMA: BearishApr 18, 20233 years ago
SMA: BullishApr 17, 20233 years ago
SMA: BullishApr 13, 20233 years ago
SMA: BearishApr 12, 20233 years ago
SMA: BullishApr 11, 20233 years ago
MACD: Buy SignalMar 29, 20233 years ago
RSI: OversoldMar 22, 20233 years ago
RSI: OversoldMar 13, 20233 years ago
SMA: BearishMar 7, 20233 years ago
SMA: BullishMar 3, 20233 years ago
SMA: BearishFeb 24, 20233 years ago
SMA: BearishFeb 10, 20233 years ago
SMA: BullishFeb 9, 20233 years ago
SMA: BearishFeb 8, 20233 years ago
MACD: Sell SignalFeb 8, 20233 years ago
SMA: BullishFeb 7, 20233 years ago
SMA: BearishFeb 6, 20233 years ago
SMA: BullishFeb 2, 20233 years ago
RSI: OverboughtFeb 2, 20233 years ago
RSI: OverboughtJan 23, 20233 years ago
MACD: Buy SignalDec 30, 20223 years ago
SMA: BullishDec 29, 20223 years ago
MACD: Sell SignalDec 22, 20223 years ago
SMA: BearishDec 19, 20223 years ago
SMA: BullishDec 8, 20223 years ago
MACD: Buy SignalNov 25, 20223 years ago
RSI: OversoldNov 9, 20223 years ago
MACD: Sell SignalNov 7, 20223 years ago
SMA: BearishNov 2, 20223 years ago
SMA: BullishOct 28, 20224 years ago
MACD: Buy SignalOct 18, 20224 years ago
MACD: Sell SignalOct 7, 20224 years ago
RSI: OversoldOct 7, 20224 years ago
MACD: Buy SignalOct 4, 20224 years ago
MACD: Sell SignalSep 23, 20224 years ago
SMA: BearishSep 13, 20224 years ago
SMA: BullishSep 12, 20224 years ago
MACD: Buy SignalSep 9, 20224 years ago
RSI: OversoldSep 6, 20224 years ago
RSI: OversoldAug 26, 20224 years ago
SMA: BearishAug 19, 20224 years ago
SMA: BullishAug 18, 20224 years ago
SMA: BearishAug 17, 20224 years ago
MACD: Sell SignalAug 17, 20224 years ago
MACD: Buy SignalAug 11, 20224 years ago
MACD: Sell SignalAug 9, 20224 years ago
SMA: BullishAug 5, 20224 years ago
SMA: BearishAug 4, 20224 years ago
SMA: BullishJul 26, 20224 years ago
MACD: Buy SignalJun 29, 20224 years ago
MACD: Sell SignalJun 6, 20224 years ago
SMA: BearishJun 3, 20224 years ago
SMA: BullishMay 23, 20224 years ago
SMA: BearishMay 19, 20224 years ago
SMA: BullishMay 17, 20224 years ago
MACD: Buy SignalMay 17, 20224 years ago
SMA: BearishMay 5, 20224 years ago
SMA: BullishMay 3, 20224 years ago
SMA: BearishApr 27, 20224 years ago
MACD: Sell SignalApr 25, 20224 years ago
SMA: BullishMar 28, 20224 years ago
MACD: Buy SignalMar 28, 20224 years ago
SMA: BearishMar 21, 20224 years ago
SMA: BullishMar 17, 20224 years ago
SMA: BearishMar 11, 20224 years ago
MACD: Sell SignalMar 11, 20224 years ago
SMA: BullishFeb 24, 20224 years ago
SMA: BearishFeb 17, 20224 years ago
SMA: BullishFeb 15, 20224 years ago
MACD: Buy SignalFeb 15, 20224 years ago
SMA: BearishFeb 2, 20224 years ago
SMA: BullishFeb 1, 20224 years ago
MACD: Sell SignalJan 26, 20224 years ago
SMA: BearishJan 25, 20224 years ago

Key statistics

Market cap
2.26B
Enterprise value
3.11B
Trailing P/E
107.90
Forward P/E
16.86
PEG ratio
1.05
Price / sales
1.86
Price / book
2.59
EPS (TTM)
0.40
Beta
1.07
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
1.66%
Revenue (TTM)
1.22B
Revenue growth
5.80%
Free cash flow
17.42M
Total cash
181.20M
Total debt
1.01B
Return on equity
2.40%
Shares outstanding
52.45M
Short % of float
16.38%
50-day average
40.46
200-day average
41.49

Analyst view

Consensus: hold

Hold
Price target (mean) 48.73 +22.6% upside
Target (low)
40.00
Target (mean)
48.73
Target (high)
58.00
Ratings (0m) 18 13 buy · 4 hold · 1 sell
  • Strong buy6
  • Buy7
  • Hold4
  • Sell1
  • Strong sell0

Next earnings

Aug 2, 2023

Expected Aug 2, 2023. Consensus EPS estimate 0.55.

Earnings history

Financials — quick view

All financials
NUVA Revenue — quarterly 317.79M
2019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 2023
NUVA Net income — quarterly 7.36M
2019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 2023
NUVA EPS — quarterly 0.14
2019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 2023

Earnings

NUVA recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Aug 2, 2023Jun 1, 20230.56———
May 10, 2023Mar 1, 20230.41———
Feb 22, 2023Dec 1, 20220.49———
Nov 9, 2022Sep 1, 20220.53———
Aug 3, 2022Jun 1, 20220.55———
May 4, 2022Mar 1, 20220.38———

Upgrades / downgrades

NUVA analyst upgrades and downgrades
DateFirmActionFromTo
May 31, 2023Morgan StanleymainEqual-WeightEqual-Weight
May 15, 2023RBC CapitalreitOutperformOutperform
May 12, 2023BarclaysmainOverweightOverweight
May 11, 2023RBC CapitalreitOutperformOutperform
May 11, 2023Morgan StanleymainEqual-WeightEqual-Weight
Feb 23, 2023JP Morganmain—Neutral

About NuVasive, Inc.

NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
nuvasive.com

News

Your note

Sign in to keep a note on NUVA — it syncs with the Stock Master app.

Insider holders

NUVA insider holders
InsiderRelationLatest transactionDateShares held
BARRY JAMES CHRISTOPHERChief Executive OfficerConversion of Exercise of derivative securityFeb 28, 202372,997
CALAFIORE MASSIMOOfficerConversion of Exercise of derivative securityFeb 28, 20227,207
FARRINGTON MICHAELOfficerConversion of Exercise of derivative securityFeb 28, 20233,117
HARBAUGH MATTHEW KChief Financial OfficerConversion of Exercise of derivative securityFeb 28, 202310,522
KADIA SIDDHARTHADirectorConversion of Exercise of derivative securityMay 26, 20223,739
NORWALK LESLIE VDirectorConversion of Exercise of derivative securityMay 31, 20223,095

Institution ownership

NUVA institution ownership
Holder% heldSharesValueReported
Blackrock Inc.16.80%8,809,702380.23MMar 30, 2023
Vanguard Group, Inc. (The)11.31%5,933,898256.11MMar 30, 2023
State Street Corporation4.09%2,143,31992.51MMar 30, 2023
Macquarie Group Limited4.08%2,142,03092.45MMar 30, 2023
Magnetar Financial LLC3.39%1,778,83176.77MMar 30, 2023
Dimensional Fund Advisors LP2.98%1,561,85567.41MMar 30, 2023

Fund ownership

NUVA fund ownership
Holder% heldSharesValueReported
iShares Core S&P Smallcap ETF7.55%3,953,828170.65MFeb 27, 2023
Vanguard Total Stock Market Index Fund3.01%1,578,10068.11MDec 30, 2022
Vanguard Small-Cap Index Fund2.57%1,343,10557.97MDec 30, 2022
iShares Russell 2000 ETF2.19%1,146,96449.50MFeb 27, 2023
Thrivent Mid Cap Stock Fund2.16%1,131,43748.83MJan 30, 2023
Delaware Group Equity Fds V-Small Cap Core Fund1.93%1,012,84943.71MNov 29, 2022
Advertisement